성호르몬은 lacrimal system, corneal anatomy and disease, aqueous humor dynamics and glaucoma, crystalline lens and cataract, retinal disease를 포함한 안과영역의 다양한 부위에 영향을 끼칠 수 있다. Androgen은 전신에 걸...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A100815897
김진주 (서울대학교 의과대학 산부인과학교실, 헬스케어시스템 강남센터) ; 유형곤 (서울대학교) ; 구승엽 (서울대학교 의학연구원 인구의학연구소, 서울대학교 의과대학 산부인과학교실,) ; Kim, Jin-Ju ; Yu, Hyeong-Gon ; Ku, Seung-Yup
2010
Korean
KCI등재,SCOPUS,ESCI
학술저널
89-98(10쪽)
0
0
상세조회0
다운로드국문 초록 (Abstract)
성호르몬은 lacrimal system, corneal anatomy and disease, aqueous humor dynamics and glaucoma, crystalline lens and cataract, retinal disease를 포함한 안과영역의 다양한 부위에 영향을 끼칠 수 있다. Androgen은 전신에 걸...
성호르몬은 lacrimal system, corneal anatomy and disease, aqueous humor dynamics and glaucoma, crystalline lens and cataract, retinal disease를 포함한 안과영역의 다양한 부위에 영향을 끼칠 수 있다. Androgen은 전신에 걸친 sebaceous glands의 발달, 분화, 지질생성 등에 관여하므로 androgen deficiency는 meibomian gland의 기능장애와 건성안에서 증발을 더욱더 심화시킬 수 있는 것으로 알려져 있다. 반면에 estrogens은 sebaceous glands의 크기, activity, 지질생성을 감소시켜 meibomian gland에서는 androgen과 반대되는 작용을 할 가능성이 있다. 성호르몬은 또한 각막의 구조와 질병경과에도 영향을 줄 수 있는데, 각막이 월경주기 제2일째 및 배란주위기에 두꺼워지며, 폐경 여성에서 여성호르몬 치료 시 각막두께가 증가한다는 사실은 estrogen levels과 각막 두께와의 연관을 시사하는 소견이라고 하겠다. Fuch's dystrophy 역시 폐경 후 여성에서 더 흔히 관찰되어, 나이에 따른 호르몬 변화가 그 원인 중 하나로 지목되고 있으며, vernal keratoconjunctivitis 환자의 각막조직에서는 estrogen과 progesterone 수용체의 overexpresson이 발견되어 역시 이들 질환에서의 성호르몬의 역할을 시사한다고 할 수 있겠다. 성호르몬은 안압에도 영향을 미칠 수 있는데, intraocular pressure와 혈중 luteinizing hormone, follicular stimulating hormone (FSH), estrone, estradiol, progesterone, testosterone과는 연관이 없는 것으로 보고한 결과도 있으나, 혈중 progesterone의 경우 특히 임신중인 여성에서 안압과의 연관관계가 보고되었으며, 또한 폐경 여성에서 혈중 남성호르몬 농도가 높을수록 안압이 상승하는 경향이 있음이 보고되었다. 한편 'Female sex'는 모든 종류의 백내장의 위험요소인 것으로 알려져 있다. 백내장으로 진단받은 여성의 경우 호르몬 측정 시 연령등을 보정하고도 폐경기에 가까운 호르몬 수치를 보였으며, 이들 백내장 환자군내에서는 estradiol과 FSH 농도 사이에 유의한 음의 상관관계가 보고되었다. 또한 DHEAS의 경우 백내장 위험도를 감소시키는 것으로 보고되었고, 그 기전으로 전구호르몬인 DHEA의 역할을 제시되고 있는데. 즉 백내장의 주요 기전 중 하나인 oxidative stress를 감소시키는 antioxidant activity를 DHEA가 보이기 때문일 것으로 추정되고 있다. 성호르몬은 망막 내 혈관의 흐름에도 영향을 줄 수 있는 것으로 알려져 있는데, 안구 내 혈류에서 여성호르몬의 긍정적인 효과와 남성호르몬의 부정적인 효과가 보고되었고, age-related macular degeneration (AMD)의 경우, estradiol이 ER-$\beta$ 수용체를 통해 보호효과가 있음이 보고되어, ER-$\beta$ 수용체가 향후 AMD 치료에서 치료적 target이 될 수도 있을 것으로 알려지고 있다. 또한 DHEAS의 경우 AMD 위험도를 증가시킬 가능성이 있으며, 당뇨로 진단받은 환자에서는 혈중 testosterone 농도는 당뇨병성 망막병증의 진행과 연관이 있는 것으로 보고되었다. 성호르몬은 안과영역의 다양한 질환과의 연관관계는 아직 추가연구가 필요한 실정이나 다양한 성호르몬이 안질환의 발생 및 경과에 영향을 줄 가능성이 있으며, 이와 같은 연관관계가 규명된다면 추후 호르몬을 통해 질환의 경과 및 예방의 가능성이 제시될 수도 있을 것으로 사료된다. 특히 폐경이후 다양한 안질환이 증가한다는 기존의 연구결과들을 고려 시, 안과영역에 있어 폐경기 여성호르몬 치료의 긍정적인 역할에 관해서는 지속적인 관심이 요구된다고 하겠다.
다국어 초록 (Multilingual Abstract)
Sex and its tropic hormones influence the lacrimal system, corneal anatomy and disease, aqueous humor dynamics and glaucoma, crystalline lens and cataract, and retinal disease. Dry eye occurs especially frequently during pregnancy, oral contraceptive ...
Sex and its tropic hormones influence the lacrimal system, corneal anatomy and disease, aqueous humor dynamics and glaucoma, crystalline lens and cataract, and retinal disease. Dry eye occurs especially frequently during pregnancy, oral contraceptive use, and after menopause, during which androgen levels decrease. Androgen control development, differentiation, and lipid production of sebaceous glands throughout the body, and androgen deficiency also leads to meibomian gland dysfunction and evaporative dry eye. On the other hand, estrogen causes a reduction in size, activity, and lipid production of sebaceous glands. Sex and its tropic hormones also influence the corneal anatomy and disease, and corneal thickening occurred on the second day of the menstrual cycle and around the time of ovulation and appeared to be related to estrogen levels. Fuchs' dystrophy is more commonly seen in postmenopausal women than men and may be linked to hormonal changes that occur with aging. In addition, overexpression of estrogen and progesterone receptors in the conjunctiva of vernal keratoconjunctivitis patients. Serum progesterone levels also may be associated with intraocular pressure especially in pregnant women, and for the women. For women with cataracts, hormone levels were typical of menopause, and there was a significant negative correlation between estradiol and follicular stimulating hormone levels. In addition, serum testosterone levels are associated with the development of diabetic retinopathy. Although the role of sex hormones on the eye is largely unknown, and the results should be interpreted with caution until replicated, the functions of sex hormones in ocular disease remains to be investigated, because they may be involved in structure and function of the ocular components, which are important in the pathogenesis of ocular disease.
참고문헌 (Reference)
1 Bonini S, "Vernal keratoconjunctivitis" 18 : 345-351, 2004
2 Loukovaara S, "Vasoactive mediators and retinopathy during type 1 diabetic pregnancy" 83 : 57-62, 2005
3 Qureshi IA, "Variations in ocular pressure during menstrual cycle" 48 : 37-40, 1998
4 Nagra PK, "Thygeson's superficial punctate keratitis: ten years' experience" 111 : 34-37, 2004
5 van Bijsterveld OP, "Thygeson's superficial punctate keratitis" 17 : 150-153, 1985
6 Hirji NK, "Thickness of human cornea measured by topographic pachometry" 55 : 97-100, 1978
7 Johnson DH, "The ultrastructure of Descemet's membrane. I. Changes with age in normal corneas" 100 : 1942-1947, 1982
8 Toker E, "The influence of sex hormones on ocular blood flow in women" 81 : 617-624, 2003
9 Dolatowska E, "The evaluation of estradiol and FSH serum levels in menopausal women with primary cataract" 104 : 357-361, 2002
10 McCarty CA, "The epidemiology of dry eye in Melbourne, Australia" 105 : 1114-1119, 1998
1 Bonini S, "Vernal keratoconjunctivitis" 18 : 345-351, 2004
2 Loukovaara S, "Vasoactive mediators and retinopathy during type 1 diabetic pregnancy" 83 : 57-62, 2005
3 Qureshi IA, "Variations in ocular pressure during menstrual cycle" 48 : 37-40, 1998
4 Nagra PK, "Thygeson's superficial punctate keratitis: ten years' experience" 111 : 34-37, 2004
5 van Bijsterveld OP, "Thygeson's superficial punctate keratitis" 17 : 150-153, 1985
6 Hirji NK, "Thickness of human cornea measured by topographic pachometry" 55 : 97-100, 1978
7 Johnson DH, "The ultrastructure of Descemet's membrane. I. Changes with age in normal corneas" 100 : 1942-1947, 1982
8 Toker E, "The influence of sex hormones on ocular blood flow in women" 81 : 617-624, 2003
9 Dolatowska E, "The evaluation of estradiol and FSH serum levels in menopausal women with primary cataract" 104 : 357-361, 2002
10 McCarty CA, "The epidemiology of dry eye in Melbourne, Australia" 105 : 1114-1119, 1998
11 Park SB, "The effect of pregnancy on corneal curvature" 18 : 256-259, 1992
12 Gharagozloo NZ, "The correlation between serum progesterone and aqueous dynamics during the menstrual cycle" 69 : 791-795, 1991
13 Risk factors for idiopathic macular holes, "The Eye Disease Case-Control Study Group" 118 : 754-761, 1994
14 Wenderlein M, "The "dry eye" phenomenon and ovarian function. Study of 700 women pre- and postmenopausal" 118 : 643-649, 1996
15 Sullivan DA, "Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye" 2 : 92-123, 2004
16 Evans JR, "Systemic risk factors for idiopathic macular holes: a case-control study" 12 (12): 256-259, 1998
17 Elliot S, "Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells" 86 : 653-660, 2008
18 Wagner H, "Sex- and gender-based differences in healthy and diseased eyes" 79 : 636-652, 2008
19 Sullivan DA, "Sex steroids, meibomian gland dysfunction and evaporative dry eye in Sjogren's syndrome" 11 : 667-, 2002
20 Defay R, "Sex steroids and age-related macular degeneration in older French women: the POLA study" 14 : 202-208, 2004
21 Coca-Prados M, "Sex steroid hormone metabolism takes place in human ocular cells" 86 : 207-216, 2003
22 Yu HG, "Sex steroid and tropic hormone levels may be associated with postoperative prognosis of vitrectomy in Korean postmenopausal women: a pilot study" 17 : 161-165, 2010
23 Zhang XH, "Sex hormones and their receptors in patients with age-related cataract" 29 : 71-77, 2003
24 Gupta PD, "Sex hormone receptors in the human eye" 50 : 274-284, 2005
25 Lei J, "Serum-stimulated alpha 1 type IV collagen gene transcription is mediated by TGF-beta and inhibited by estradiol" 274 : f252-f258, 1998
26 Bandeen-Roche K, "Self-reported assessment of dry eye in a population-based setting" 38 : 2469-2475, 1997
27 Davis MD, "Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18" 39 : 233-252, 1998
28 Defay R, "Relationships between hormonal status and cataract in french postmenopausal women: the POLA study" 13 : 638-644, 2003
29 Moss SE, "Prevalence of and risk factors for dry eye syndrome" 118 : 1264-1268, 2000
30 Qureshi IA, "Ocular hypertensive effect of menopause with and without systemic hypertension" 75 : 266-269, 1996
31 Lim KJ, "Ocular dimensions with aging in normal eyes" 6 : 19-31, 1992
32 Kiely PM, "Menstrual cycle variations of corneal topography and thickness" 60 : 822-829, 1983
33 Mathers WD, "Menopause and tear function: the influence of prolactin and sex hormones on human tear production" 17 : 353-358, 1998
34 Weinreb RN, "Maternal corneal thickness during pregnancy" 105 : 258-260, 1988
35 Sanchis-Gimeno JA, "Martinez-Soriano F. Reduced corneal thickness values in postmenopausal women with dry eye" 24 : 39-44, 2005
36 Razeghinejad MR, "Lesser anterior chamber dimensions in women may be a predisposing factor for malignant glaucoma" 64 : 572-574, 2005
37 Hulsman CA, "Is open-angle glaucoma associated with early menopause? The Rotterdam Study" 37 (37): 138-144, 2010
38 Qureshi IA, "Intraocular pressure: association with menstrual cycle, pregnancy and menopause in apparently healthy women" 38 : 229-234, 1995
39 Toker E, "Influence of serum levels of sex hormones on intraocular pressure in menopausal women" 12 : 436-440, 2003
40 Loukovaara S, "Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes" 19 : 422-430, 2005
41 Haffner SM, "Increased testosterone in type I diabetic subjects with severe retinopathy" 97 : 1270-1274, 1990
42 Hill DJ, "Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women with retinopathy" 82 : 1452-1457, 1997
43 Sullivan BD, "Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions" 506 : 449-458, 2002
44 Schirra F, "Identification of steroidogenic enzyme mRNAs in the human lacrimal gland, meibomian gland, cornea, and conjunctiva" 25 : 438-442, 2006
45 Wickham LA, "Identification of androgen, estrogen and progesterone receptor mRNAs in the eye" 78 : 146-153, 2000
46 Manchester PT Jr, "Hydration of the cornea" 68 : 425-461, 1970
47 Schaumberg DA, "Hormone replacement therapy and dry eye syndrome" 286 : 2114-2119, 2001
48 Qureshi IA, "Hormonal changes associated with menstrual cycle have no definite influence on ocular pressure" 21 : 49-53, 1997
49 Huber JC, "Genetic modelling of the estrogen metabolism as a risk factor of hormonedependent disorders" 42 : 1-12, 2002
50 Yamagami H, "Gender-associated differences in gene expression 성호르몬과 안질환 대한생식의학회지 of the meibomian gland" 506 : 459-463, 2002
51 Brubaker RF, "Flow of aqueous humor in humans [The Friedenwald Lecture]" 32 : 3145-3166, 1991
52 Potier M, "Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9" 12 : 241-251, 2001
53 Bonini S, "Estrogen and progesterone receptors in vernal keratoconjunctivitis" 102 : 1374-1379, 1995
54 Affinito P, "Effects of hormone replacement therapy on ocular function in postmenopause" 10 : 482-487, 2003
55 Warren DW, "Effects of dihydrotestosterone and prolactin on lacrimal gland function" 350 : 99-104, 1994
56 Sorrentino C, "Effect of hormone replacement therapy on postmenopausal ocular function" 50 : 19-24, 1998
57 Nichols KK, "Dry eye in postmenopausal women enrolled in the observational study cohort of the Women's Health Initiative [ARVO Abstract]" 44 : 2462-, 2003
58 Abramov Y, "Does postmenopausal hormone replacement therapy affect intraocular pressure?" 14 : 271-275, 2005
59 Feldman F, "Daily assessment of ocular and hormonal variables throughout the menstrual cycle" 96 : 1835-1838, 1978
60 Kumagai K, "Clinical features of idiopathic macular holes" 104 : 819-2557, 2000
61 Serrander AM, "Changes in contact lens comfort related to the menstrual cycle and menopause. A review of articles" 64 : 162-166, 1993
62 el-Hage SG, "Changes in central and peripheral corneal thickness with menstrual cycle" 50 : 863-871, 1973
63 Barney NP, "Can hormone replacement therapy cause dry eye?" 120 : 642-, 2002
64 Ziai N, "Beta-human chorionic gonadotropin, progesterone, and aqueous dynamics during pregnancy" 112 : 801-806, 1994
65 Tamer C, "Androgen status of the nonautoimmune dry eye subtypes" 38 : 280-286, 2006
66 Pasquale LR, "Age at menopause and primary open-angle glaucoma: a prospective study [ARVO Abstract]" 44 : 795-, 2003
말초혈액 자연살해세포 분획 및 세포용해 활성도 분석을 통한 습관성 유산 위험군의 진단적 유용성에 관한 연구
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2024 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2021-01-01 | 평가 | 등재학술지 선정 (해외등재 학술지 평가) | ![]() |
2020-12-01 | 평가 | 등재후보로 하락 (해외등재 학술지 평가) | ![]() |
2012-01-05 | 학술지명변경 | 한글명 : 대한생식의학회지 -> Clinical and Experimental Reproductive Medicine외국어명 : The Korean Journal of Reproductive Medicine -> Clinical and Experimental Reproductive Medicine | ![]() |
2010-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2007-08-28 | 학술지명변경 | 한글명 : 대한불임학회지 -> 대한생식의학회지외국어명 : The Korean Journal of Fertility and Sterility -> The Korean Journal of Reproductive Medicine | ![]() |
2007-08-28 | 학회명변경 | 한글명 : 대한불임학회 -> 대한생식의학회영문명 : Korean Society For Fertility And Sterility -> The Korean Society for Reproductive Medicine | ![]() |
2007-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | ![]() |
2006-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | ![]() |
2004-07-01 | 평가 | 등재후보학술지 선정 (신규평가) | ![]() |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0 | 0 | 0 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0 | 0 | 0 | 0 |